Mother and Daughter Hugging

Lenabasum in dermatomyositis clinical trial

Corbus Pharmaceuticals is now recruiting dermatomysitis patients for an exciting phase 3 clinical trial for lenabasum. The trial, known as DETERMINE, is designed to evaluate the efficacy and safety of lenabasum for the treatment of dermatomyositis.

Continue Reading
Mother and Daughter Hugging

Lenabasum questions answered

Excitement is building for Corbus Pharmaceutical’s Phase 3 clinical trial testing the safety and effectiveness of their new drug lenabasum in dermatomyositis patients.

Continue Reading
Woman thinking

You may qualify for a research study

Bristol-Myers Squibb is currently sponsoring a research study for patients with systemic lupus erythematosus (SLE). People diagnosed with lupus can sometimes also develop myositis, an inflammation of the skeletal muscles that causes weakness and loss of strength.

Continue Reading